תבנית:תרופה/רימודולין 10 מ"ג/מ"ל - Remodulin 10 mg/ml

× ×ª×× × ×ª×¨××¤×

×××¨×©×

××× ×× ×× × ××¡×¤××	×¨×××××××× 2.5 ×"×/×"× - Remodulin 2.5 mg/ml ×¨×××××××× 5 ×"×/×"× - Remodulin 5 mg/ml
×§×××¦× ×¤×¨××§××××××ª (ATC4)	B01AC Platelet aggregation inhibitors excluding heparin
××¨××× ×¤×¢×× (ATC5)	Â Treprostinil AS SODIUM 10MG/ML âB01AC21
×¦××¨×ª ××ª×	×ª×ª-×¢××¨×, ×ª××-××¨××× - S.C, I.V
×¦××¨×ª ××× ××	×ª×××¡× ××××¨×§×, SOLUTION FOR INJECTION ××× ××¢×ª ××× ×× ××ª×¨ ×× ××¨×¢×× ××© ××××× ××ª ××ª×¨××¤× ×××ª×× ×××× ×× ××××××¥ ××¤× ×©×××¤××¢ ××¢××× ××¦×¨××
××ª××××	Remodulin is indicated as a continuous subcutaneous infusion or intravenous infusion for the treatment of primary pulmonary arterial hypertension and pulmonary arterial hypertension associated with connective tissue disorders. Pulmonary hypertension associated with congenital systemic to pulmonary shunts.
×ª×× ××ª:× ×ª×× × ×¡×/×ª×¨××¤×/×¨×××××××× 10 ×"×/×"× - Remodulin 10 mg/ml
×¢××× ××¨××¤× ×××××¨××ª ××¢×××	Â ×¢××× ××¨××¤× 27.07.2020 Â ××××¨× ××¢××× 27.07.2020 ××××¨× ××¢××× 24.04.2012

×¢××× ××¦×¨××	Â ×¢××× ××¦×¨×× ×¢××¨××ª 27.07.2020 ×¢××× ××¦×¨×× ×¢×¨×××ª - ÙØ´Ø±Ø© ÙÙÙØ³ØªÙÙÙ Ø¨Ø§ÙÙØºØ© Ø§ÙØ¹Ø±Ø¨ÙØ© 27.07.2020 ×¢××× ××¦×¨×× ×× ××××ª - Patient information leafletâ 27.07.2020

×¢×¨××× ×××××§××¨×¤×××	×¢×¨××× ×§×©××¨×× ×××××§××¨×¤×××
×¨×××××××× 10 ×"×/×"× ×××××¨ ××©×¨× ×××¨××××ª

×××¤××© ××××¨××	-
××××¢ ××¨×©×ª	-
×©× ××¦×¨×	UNITED THERAPEUTICS CORP., USA
×©× ××¢× ××¨××©××	RAFA LABORATORIES LTD
×¨××©×××	×ª××¨×× ×××©×: 03/2005. ×¨××©××× ××ª××¨××: 01/2016
×ª××¨×× ×¢×××× ×××¨××	15/05/19

×ª××× ×ª ××¨×××

×ª××× ×ª ××¨×××

××£ ×× × ××¦×¨ ×¢× ××× ××× ××××××¨ ×ª×× ××ª ×¢× ×¤×¨×× ××ª×¨××¤×.

{{×ª×¨××¤×/ml}}

×:

{{×ª×¨××¤×/ml
| ×©× ××¤×¨×××¨=×¢×¨× ×××© (×××¨×¡ ××ª ××¢×¨× ×©×××× ×××××¨)
}}

השינוי האחרון נעשה בֹ־7 באפריל 2023 ב־15:50

ויקיתרופות